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Wilfrido Coronell-Rodriguez3, Fernando Salcedo-Mejía4, Nelson Alvis-Guzmán5
Abstract
Objective: To identify predisposing factors to developing severe pneumonia in hospitalized 
children diagnosed with community-acquired pneumonia hospitalized in Cartagena’s Napoleón 
Franco Pareja children’s Hospital.
Methods: Analytical observational cross-sectional study performed in patients under 18 years. 
Data from surveys and records were analyzed. Univariate and bivariate analysis was performed. 
The variables are grouped according to the presence or absence of complications and analyzed 
by ji-square test. We calculated OR of each of the dummy variables to evaluate their association 
with complications. A P < 0.05 was considered statistically significant for all analyses.
Results: 301 patients with severe pneumonia were included. Risk factors related to severity: age 
less than 3 months (OR: 4.86; CI 95%: 1,5 - 14.3; p = 0.004); exclusive breastfeeding for less 
than 6 months (CI:95% 7,7- 1,4; p = 0.0019); heart disease (OR: 5.37; CI 95%: 1,28- 19,88, p 
= 0.010); prematurity (OR: 1.62, CI 95%: 0.93- 6.69, p = 0.034); Incomplete vaccination (OR: 
2.32; CI: 95% 1.07 - 5.10; p = 0.015). 
Conclusions: It was found increased severity risk, statistically significant, in patients less 
than 6 months breastfeeding, prematurity, heart disease, incomplete vaccination scheme, and 
positive blood culture with Sp. pneumonia
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Resumen
Objetivo: Identificar factores predisponentes a desarrollar neumonía severa en niños 
hospitalizados con diagnóstico de NAC en el Hospital Infantil Napoleón Franco Pareja de 
Cartagena Colombia.
Materiales y métodos: Estudio observacional transversal analítico en pacientes menores 
de 18 años hospitalizados con neumonía adquirida en la comunidad. Se analizaron datos 
obtenidos de encuestas  y registros clínicos. Se realizó un análisis descriptivo univariado y 
bivariado. Las variables se agruparon según la presencia o no de complicación y se analizaron 
a través de la prueba ji cuadrado. Se realizó el cálculo de OR de cada una de las variables 
dicotómicas para evaluar su asociación a complicaciones. Una P<0,05 fue considerada como 
estadísticamente significativa para todos los análisis.
Resultados: Se incluyeron 301 pacientes con neumonía grave. Los factores de riesgo más 
relacionados con severidad fueron: edad menor de 3 meses (OR: 4,86; IC 95%: 1,5- 14,3; p 
0,004); la lactancia materna exclusiva menor a 6 meses (IC 95%: 1,4- 7,7; p 0,0019); car-
diopatía (OR: 5,37; IC 95%: 1,28- 19,88; p: 0,010); prematurez (OR: 1,62; IC: 0,93-6,69; p: 
0,034); esquema incompleto de vacunación (OR: 2,32; IC 95%: 1,07-5,10: p: 0,015).
Conclusiones: Se encontró aumento de riesgo de severidad en pacientes con lactancia materna 
menor de 6 meses, prematurez, cardiopatía, esquema de vacunación incompleto, y hemocultivo 
con Sp. Neumoniae positivo.
Palabras clave: neumonía, taquipnea, Streptococcus pneumoniae.
IntroductIon
Acquired Pneumonia in the Community (CAP) 
is the leading cause of death in children under 
5 years of age in the world, with about 1.2 
million cases in 2015 (1).  The most vulnerable 
population is found in the developing countries, 
especially children under 1 year old, in whom 
the severe form of this entity prevails, increasing 
in them the risk of death (2, 3). This is due to 
socioeconomic conditions, difficulties in access 
and quality of healthcare services, malnutrition 
and low vaccination coverage (4, 5).  
Every year between 140 and 160 million new 
CAP’s cases are reported, with a lethality of 4% 
in hospitalized patients and 1% in outpatient 
(6). According to WHO, each year one of each 
20 children under 5 years will have an episode 
of pneumonia, and of these, one to four of every 
thousand will require hospitalization (7, 8).  In 
2010, 120 million episodes of pneumonia were 
estimated in children under 5 years old, of 
whom 1.3 died (81% in the first 2 years of life)
(1). Streptococcus pneumoniae (Sp) is respon-
sible for 18.3% of these cases (9, 10) CAP was 
confirmed in children under 3 years old by 
this germ, in Latin America: a rate of 55 per 
100,000 children in Brazil and 76 per 100,000 
children in Bogota, Colombia,  in 2012 (11).
Risk factors have been described to develop 
severe pneumonia  (12). Among these we 
find: low birth weight(13, 14), prematurity 
(15, 16), being younger than 3 months old 
(17), breastfeeding not exclusive (18), teena-
ger or unlearned mother (19), meeting at day-
care centers, overcrowding, malnutrition 
(20, 21), immunocompromised, presence 
of congenital heart disease or chronic lung 
disease (17), exposure to cigarette smoke or 
biomass (22), incomplete vaccines schedule 
(23), late medical care (24), and others (15, 24, 
25). WHO seeks to reduce the morbidity and 
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mortality caused by CAP through the identifi-
cation and dissemination of these factors (12). 
There are no studies in our population that 
determine the vulnerability of some children 
with CAP to develop complications. The 
main objective of this study is to identify 
predisposing risk factors to develop severe 
pneumonia in hospitalized children diagnosed 
with community-acquired pneumonia in the 
Colombian Caribbean.
Methods
An analytical cross-sectional observational 
study was realized that looked to identify pre-
disposing factors to develop severe pneumonia 
in hospitalized children diagnosed with CAP in 
the Napoleón Franco Pareja Children’s Hospital 
(HINFP) between January and December 2014.
Study Subjects
It was included Children younger than 18 years 
old of both sex with a diagnosis of CAP ac-
cording to definitions of WHO, British’s Chest 
Society and American Society of Infectious 
Diseases; who were admitted at emergency 
service (15-17) and were hospitalized for more 
than 24 hours. Children admitted to Intensi-
ve Care Unit (ICU) from another institution, 
and patients forwarded to another institution 
without observable evolution were excluded.
Data collection and statistical analysis
A form was designed that included clinical 
record’s information and the interview with 
parents and / or caregivers with prior infor-
med consent. Socioeconomic variables (table 
1), epidemiological variables (table 2), clinics 
(signs and symptoms, complications, hospital 
staying, oxygen therapy, condition at de-
parture, paraclinical record) were included.
Table 1. Socioeconomic Profile of patients 
with CAP in the Napoleón Franco Pareja 
Children’s Hospital (HINFP) in 2014
Total (n): 301
Age:
(Half); SD
[Median]
[Rank]
(2,52); 2,90
[1.57]
[.0739726 - 15.21096]
Sex:
Male n; (%) 159, (52,82%)
Social Security:
Contributory (%)
Particular (%)
Subsidized (%)
Linked (%)
6 (1,99 %)
3 (1%)
286 (95,02 %)
6 (1,99%)
Socioeconomic:
Stratum 1 (Low-Low)
Stratum 2 (Low)
Stratum 3 (Medium-Low)
236 (78.41%)
50(16.61%)
15 (4.98%)
Geographic Location 
(Provenance)
Urban (%)
Rural (%)
257(85,38%)
44(14,62%)
Condition of overcrowding (%): 109(36,21%)
Maternal age in years:
(Half); SD
[Median]
[Rank]
(23.64); 5,79
[22]
[15 - 48]
Maternal Education:  
Without education
Primary
High school
Higher
3 (1%)
28(9,3%)
223 (74,09%)
47 (15,61%)
The data were integrated into a spreadsheet 
for MS Excel 2010™. The statistical package 
Stata 11 was used to analyze the informa-
tion. Categorical variables were measured 
in percentages and continuous variables 
were measured with central tendency and 
dispersion’s measure. Contingency tables 
were used as a measure of association bet-
ween categorical variables, measuring their 
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statistical significance with the chi-square test 
and the exact Fisher test for small frequencies. 
The Relative Risk (RR) of each factor and its 
confidence interval were calculated. All the 
statistical tests were contrasted with a level 
of significance of 5%.
Table 2. Epidemiological profile of patients 
with CAP hospitalized in HINFP in 2014.
N %
Personal history:
Asthma 104 34,6
Allergies 15 5,0
Diabetes 3 1,0
Down 1 0,3
Sickle cell anemia 11 3,7
Cardiopathy 13 4,3
Prematurity 35 11,6
Hospitalized last month by CAP 11 3,7
Exposure to fumes 63 20,9
Smoke 28 9,3
Exposure to painting 8 2,7
Malnutrition 18 6,0
Others* 38 12,6
Vaccination scheme **
Full Pentavalent + DPT 
Vaccination
239 79,4
S. pneumoniae Vaccination 240 79,7
Influenza Vaccination 234 77,7
*1 Case of: Tuberculosis, Cholelithiasis, Cystic Fibrosis, 
Cleft Lip, Bronchopulmonary Dysplasia, Esophageal 
Atresia, Ulcerative Colitis, Thalassemia, Myelomenin-
gocele, Osteosarcoma, Esophageal Atresia and S. De 
Moebius. 2 Cases of: Recurrent Pneumonia, Gastroe-
sophageal Reflux, Cerebral Palsy. 3 Cases of: Tracheos-
tomy and Epilepsy.
** Vaccination scheme verified by card.
Ethical issues
According to the resolution 008430 of 1993, 
the then Ministry of Health, the study was 
categorized safe and approved by the Carta-
gena University’s Medicine faculty’s research 
department.
Results
There were 15,546 discharges at HINFP in 
2014; of which 1,475 (9.5%) were diagnosed 
with pneumonia (Graph 1); Of these, 325 pa-
tients with diagnosis of CAP were selected. 
301 (20.4%) met the inclusion criteria. The 
reasons for exclusion were: 8 for incomplete 
data; 4 did not meet definition of NAC; 1 was 
over 18 and 11 were under 24 hours.
Tables 1 and 2 summarize the socioeconomic 
and epidemiological characteristics of the 
subjects studied. There were no differences 
regarding sex. The average age in years was 
2.5 (SD: 2.9) and the median was 1.5 with IQR 
(0.07 - 15.2). 85.3% came from urban areas 
and 78.4% had socioeconomic strata 1. 95% 
of patients were in a subsidized regime of 
social security. The median age of the mother 
was 22 years (IQR: 15 - 48). The most frequent 
clinical antecedents were asthma, prematurity, 
exposure to smoke, presence of allergies and 
heart disease. 79.4% had a complete vaccina-
tion scheme for pentavalent and DPT; 79.7% 
for pneumococcus and 77.7% for influenza.
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Fuente:
Graphic 1. Proportion of disbursements by NAC with respect to the total of 
disbursements in Napoleón Franco Pareja Children’s Hospital Foundation in 2014
Clinical profile
50% of the patients consulted on the third day 
after the onset of symptoms (average of 4.1 
days, SD: 3.4). The average stay was 6.0 days 
(SD: 5.5 and range: 1-56 days). In the general 
ward, the average stay was 5.0 days (SD: 3.9) 
and in the ICU it was 9.2 (SD: 5.2). Cough, res-
piratory distress, rhinorrhea, abdominal pain 
and vomiting were the most frequent initial 
symptoms. 69.1% of the patients presented 
tachypnea and 66.4% of these had chest wall 
indrawing. Oxygen therapy was required in 
138 patients (45.8%); of these, 18.8% requi-
red mechanical ventilation. The most used 
antibiotic schemes were: penicillin (63.8%); 
ceftriaxone (16.3%); ceftriaxone / clindamycin 
(5.0%). Two deaths were recorded in the group, 
in which one had malnutrition and the other 
sepsis as a complication (Table 3).
Table 3. Clinical profile hospitalized 
with NAC in HINFP in 2014
n= 301 %
Signs and symptoms:
Fever 258 85,7
Cough 245 81,4
Respiratory difficulty 208 69,1
Rhinorrhea 97 32,2
Abdominal pain 27 9,0
Vomit 17 5,7
Tachypnea 208 69,1
Chest wall indrawing 200 66,5
Oxygen Support:
Oxygen requirement 138 45,9
Mechanic ventilation 26 18,84
Hospitalization room
General room 267 88,7
ICU 34 11,3
Final Condition
Alive 299 99
Dead 2 1,0
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Patients were classified as presenting severe 
pneumonia (88.7%) and very severe pneu-
monia (11.3%). 44 (14,6%) of the patients 
presented complications; Of these, 7.5% had 
severe pneumonia and 70.6% had very seve-
re pneumonia, the statistical difference was 
significant (p = 0.000). The most frequent com-
plication in the group of severe pneumonia 
was pleural effusion (5.6%) and in the group 
of very severe pneumonia, sepsis (52.94%). 
Some patients presented several antecedents 
(table 4).
Table 4. Frequency of complications in patients with NAC hospitalized 
at the Napoleón Franco Pareja Children’s Hospital in 2014
CAP
TOTAL
N=301
CAP
Severe
N=267 
(88,7%)
CAP
Very severe
N=34 
(11,3%)
Pr 
(Z < z)
Complications 44 (14,6%) 20 (7,5%) 24 (70,6%) 0.000
Pleural effusion 22 (7,3%) 15 (5,6%) 7 (20,6%) 0.001
Sepsis 20 (6,6%) 2 (0,7%) 18 (52,9%) 0.000
Atelectasis 5 (1,6%) 2 (0,7%) 3 (8,8%) 0.000
Empiema 2 (0,6%) 1 (0,4%) 1 (2,9%) 0.041
Pulmonary abscess 1 (0,3%) 0 (0,0%) 1 (2,9%) 0.003
Pneumothorax 1 (0,3%) 0 (0,0%) 1 (2,9%) 0.003
Pulmonary hypertension 1 (0,3%) 0 (0,0%) 1 (2,9%) 0.003
Risk factors of severity 
Table 5 shows the risk factors and their as-
sociation with severe pneumonia. The most 
related to severity are: age less than 3 months 
(OR: 4.8, 95% CI: 1.5- 14.3, p 0.004); exclusive 
breastfeeding less than 6 months (95% CI: 1.4-
7.7, p 0.0019); heart disease (OR: 5.4, 95% CI: 
1.3- 19.9, p: 0.010); prematurity (OR: 1.6, CI: 
0.9-6.7, p: 0.034); incomplete vaccination sche-
me (OR: 2.3, 95% CI: 1.1-5.1: p: 0.015). There 
wasn’t any statistically significant difference 
between sex and severe pneumonia; However, 
the male sex had a 50% higher risk (OR 1.59, CI: 
0.73- 3.59, p: 0.13). History of overcrowding, 
exposure to smoke or biomass and asthma 
didn’t show differences between patients with 
severe and very severe pneumonia.
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Table 5. Risk factor for severity CAP  at Napoleón Franco Pareja Children’s Hospital in 2014
Risk factor
CAP
Severe
CAP
Very severe
Total
Pr(X2) OR
CI95% 
Lower
CI95% 
Upper
P
n % n % n %
Sex
Male 137 51,5 22 62,9 159 52,82 0,21 1,59 0,73 3,59 0,139
Female 129 48,5 13 37,1 142 47,18
Age <= 3 
month
Yes 13 4,9 7 20,0 20 6,64 0,00 4,87 1,50 14,36 0,004
No 253 95,1 28 80,0 281 93,36
Mother’s age 
<20 years
Yes 64 24,1 9 25,7 73 24,25 0,83 1,09 0,43 2,56 0,487
No 202 75,9 26 74,3 228 75,75
Breastfeeding 
<6 moths
Yes 117 44,0 25 71,4 142 47,18 0,00 3,18 1,40 7,71 0,002
No 149 56,0 10 28,6 159 52,82
Mother with no 
education
Yes 2 0,8 1 2,9 3 1 0,02 3,88 0,06 75,89 0,311
No 264 99,3 34 97,1 298 99
Incomplete 
vaccination
Yes 97 36,5 20 57,1 117 38,87 0,02 2,32 1,07 5,11 0,016
No 169 63,5 15 42,9 184 61,13
Overcrowding
Yes 96 36,2 13 37,1 109 36,33 0,92 1,04 0,46 2,27 0,527
No 169 63,8 22 62,9 191 63,67
Malnutrition
Yes 14 5,3 4 11,4 18 5,98 0,15 2,32 0,52 8,00 0,143
No 252 94,7 31 88,6 283 94,02
Exposure to 
tobacco
Yes 25 9,4 3 8,6 28 9,3 0,87 0,90 0,17 3,23 0,585
No 241 90,6 32 91,4 273 90,7
Exposure to 
smoke
Yes 52 19,6 11 31,4 63 20,93 0,10 1,89 0,78 4,30 0,084
No 214 80,5 24 68,6 238 79,07
Cardiopathy
Yes 8 3,0 5 14,3 13 4,32 0,00 5,38 1,29 19,89 0,010
No 258 97,0 30 85,7 288 95,68
Late medical 
consultation
Yes 86 32,3 10 28,6 96 31,89 0,65 ND
No 180 67,7 25 71,4 205 68,11
Asthma
Yes 94 35,3 10 28,6 104 34,55 0,43 0,73 0,30 1,66 0,277
No 172 64,7 25 71,4 197 65,45
Allergies
Yes 15 5,6 0 - 15 4,98 0,15 ND
No 251 94,4 35 100,0 286 95,02
Diabetes
Yes 3 1,1 0 - 3 1 0,53 ND
No 263 98,9 35 100,0 298 99
Down
Yes 1 0,4 0 - 1 0,33 0,72 ND
No 265 99,6 35 100,0 300 99,67
Sickle cell 
anemia
Yes 10 3,8 1 2,9 11 3,65 0,79 0,75 0,02 5,60 0,627
No 256 96,2 34 97,1 290 96,35
Continúa...
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Risk factor
CAP
Severe
CAP
Very severe
Total
Pr(X2) OR
CI95% 
Lower
CI95% 
Upper
P
n % n % n %
Prematurity
Yes 27 10,2 8 22,9 35 11,63 0,03 2,62 0,93 6,69 0,034
No 239 89,9 27 77,1 266 88,37
Hospitalised 
with CAP
Yes 10 3,8 1 2,9 11 3,65 0,79 0,75 0,02 5,60 0,627
No 256 96,2 34 97,1 290 96,35
Exposure to 
painting
Yes 8 3,0 0 - 8 2,66 0,30 ND
No 258 97,0 35 100,0 293 97,34
Others
Yes 29 10,9 9 25,7 38 12,62 0,01 2,83 1,06 6,98 0,019
No 237 89,1 26 74,3 263 87,38
Microbiological profile
5% of the 180 blood cultures performed were 
positive. The most frequent germ isolated was 
S. pneumoniae with 5 cases, 4 of them were 
admitted in ICU: 1 had not vaccination against 
pneumococcus, 2 received breastfeeding less 
than 6 months, one had sickle cell anemia and 
heart disease. Four had a pleural effusion and 
two presented sepsis as complications too. The 
virological tests carried out, were positive so: 
4.5% for influenza A, 4.4% for influenza B, 
14% for H1N1 and 36.5% for RSV (Table 6).
Table 6. CAP microbiological 
profile at Napoleón Franco Pareja 
Children’s Hospital in 2014
N=301 %
Blood cultures 180 59,8
Positive 9 5,0
E.coli 1 11,1
Micrococus 1 11,1
S. Aureus 1 11,1
S. Pneumoniae 5 55,5
S. Epidermidis 1 11,1
Viral panel made 44 14,6
Influenza A 44 14,6
N=301 %
Negative 42 95,5
Positive 2 4,6
Influenza B 45 14,9
Negative 43 95,6
Positive 2 4,4
H1N1 50 16,6
Negative 43 86,0
Positive 7 14,0
RSV 52 17,3
Negative 33 63,5
Positive 19 36,5
Discussion
This study analyzes the socioeconomic, epi-
demiological, clinical characteristics and most 
frequent complications found in children 
with severe and very severe CAP in a pedia-
tric hospital, and their relationship with risk 
factors associated with this clinical evolution.
The WHO and the British Chest Society define 
CAP as the presence of tachypnea associated 
with symptoms of fever, cough and chest 
wall indrawing(26, 27). Tachypnea occurs 
due to activation of an inflammatory cascade 
induced by a germ that alters gas exchange Continúa...
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at the alveolocapillary level; When it is not 
compensated, it evolves to chest retractions, 
nasal flaring, whining, signs of shock and ven-
tilatory failure with a high risk of death. (28). 
Shann, Spooner and Levental’s studies 
showed that the tachypnea and chest wall 
indrawing as diagnostic signs established 
by the WHO have high predictive value in 
children less 2 years old. (29, 30). However, 
in our study, 30.9% of the children didn’t pre-
sent tachypnea, but  radiological findings and 
complications such as pleural effusion were 
found in them, which is consistent with other 
established consensus such as the American 
Society of Infectious Diseases, which defines 
CAP as the presence of signs and symptoms of 
pneumonia that can be confirmed by findings 
of infiltrates in chest X-rays, in previously 
healthy children acquired before hospital 
admission (31). 
Only 66.5% of studied children presented chest 
wall indrawing, that indicates it shouldn’t be 
considered as the only criterion of severity. 
Other findings such as cyanosis, oxygen the-
rapy, complicated pneumonia or the presence 
of highly virulent germs such as S. aureus are 
also included in this concept (27, 31). 
Majorities of CAP are managed ambulatorily, 
but if there is any criterion of severity such 
as: respiratory distress, oxygen requirement, 
intolerance to the oral route, cyanosis, chest 
wall indrawing, to be less than 3 months old 
is considered hospital treatment. The subjects 
studied had some of these conditions, because 
of that, they were classified as severe pneu-
monia (88.7%).
Patients with CAP who present imminent 
signs of ventilatory failure, hemodynamic 
instability, needing for ventilatory and / or 
inotropic support are classified as very severe 
pneumonia and require ICU treatment (32). In 
our study, ten of the patients classified in this 
category didn’t present complications associa-
ted with shock or these supports. However, 
they were at risk of ventilatory failure requi-
ring continuous monitoring, which explains 
their admission to the ICU (32). 
In our study, complications from CAP were 
presented independently of their severity; 
the risk of complications in very severe CAP 
was higher, sepsis and atelectasis were more 
common in this group. Although the develo-
pment of empyema in comparison with other 
complications wasn’t as relevant, it was more 
common in very severe CAP with a statistically 
significant difference (p = 0.041).
Pneumonia cases increase in the rainy season, 
due to the spread of respiratory pathogens 
from person to person, and the dryness of 
mucous membranes is facilitated, which al-
ters their mucociliary function (15). In 2014, 
pneumonia cases occurred throughout the 
year, with peaks between June and July and 
in November, which could be associated with 
increased rains during these dates.
Although belonging to the male sex is associa-
ted with severity (33), In our study there were 
no differences in relation to sex. Being younger 
than 3 months or premature, were common 
factors in these children and coincides with 
the risk of severity described in the literature.
Breast milk is rich in secretory IgA that pre-
vents the adherence of viruses and bacteria to 
the respiratory mucosa, so its exclusive con-
sumption during the first 6 months of life is a 
protective factor (15, 25). In this sample, it was 
found that not having this condition tripled 
the risk of severity. When severe malnutrition 
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occurs, the immune response decreases, faci-
litating the development of severe CAP (12). 
In our population, malnutrition doubled the 
risk of severity (OR 2.32, 95% CI: 0.52-8.00, p: 
0.14), including death, evidenced in two cases.
Comorbidities like sickle cell anemia, bron-
chopulmonary dysplasia, gastroesophageal 
reflux, asthma, cystic fibrosis, congenital heart 
disease or immunodeficiency are associated 
to complications and neuromuscular disease 
and epilepsy to aspiration pneumonia(34). In 
our study, heart disease was associated with 
very severe pneumonia (p 0.010); However, 
asthma or sickle cell anemia did not increase 
the risk of admission to the ICU due to very 
severe pneumonia, it’s possible that the pre-
sence of other factors that increase this risk 
may be required.
Active vaccination has been considered a 
significant resource to reduce morbidity and 
mortality by CAP (15). Studies describe that 
immunization against Haemophilus influenza 
and S pneumoniae reduced the radiological 
incidence of CAP by 20%(35). Incomplete 
vaccination was associated with severe pneu-
monia in our population.
Environmental contamination and exposure 
to smoke or biomass, block the mucociliary 
response of the respiratory tract (15). Over-
crowding (12) facilitates nasopharyngeal 
colonization of germs, this and the late con-
sultation (24) are associated with risk of se-
verity. In our study, there were no differences 
between severe and very severe CAP when 
these factors were associated.
It is known that it is difficult to determine 
the etiological agent of pneumonias in the 
world (19, 20). Blood cultures are positive in 
less than 10% of cases (21, 22). In our study, 
only 5% of the blood cultures were positi-
ve. The most frequent isolated germ was S. 
pneumoniae, which was associated with very 
severe pneumonia and complications, but not 
death. Despite the expectation that these cases 
had a history of incomplete vaccination for 
pneumococcus, only one met this criterion. 
This suggests that it is possible that the strain 
present in these cases isn’t covered by the 
vaccine. New studies should be carried out 
to establish the pneumococcal subtype in this 
population and correlate it with those present 
in the vaccine applied by the EPI.
conclusIons
CAP is one of the infectious causes with greater 
morbidity and mortality in our environment. It 
can be associated to risk factors that predispose 
to the development of severity. In our study, 
we found exclusive breastfeeding for under six 
months since birth, prematurity, heart disease, 
incomplete vaccination and blood cultures 
positive for S. pneumoniae increased risk of 
significant severity. Working on measures 
that modify these risk factors could reduce 
complications, hospital staying and death, 
which in turn would reduce costs. For this 
reason, the training of health personnel and 
the vulnerable population is essential.
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